ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03026348
Recruitment Status : Completed
First Posted : January 20, 2017
Last Update Posted : August 31, 2018
Sponsor:
Information provided by (Responsible Party):
Novavax

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2017
  Actual Study Completion Date : May 18, 2018